Neuberger Berman ETF Insiders
| NEMD Etf | USD 52.23 0.03 0.06% |
Evaluation of Neuberger Berman's management performance can provide insight into the fund performance.
Neuberger | Build AI portfolio with Neuberger Etf |
| Symbol | NEMD |
| Name | Neuberger Berman Emerging |
| Type | Etf |
| Country | United States |
| Exchange | NYSE |
Information on Neuberger Berman Emerging Leadership is currently not available.
If you believe this information is not accurate please let us know and we will check it out. Check all delisted instruments across multiple markets.Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Thematic Opportunities
Explore Investment Opportunities
Neuberger Berman Management Team Effectiveness
The company has return on total asset (ROA) of (168.84) % which means that it has lost $168.84 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (20.1) %, meaning that it created substantial loss on money invested by shareholders. Neuberger Berman's management efficiency ratios could be used to measure how well Neuberger Berman manages its routine affairs as well as how well it operates its assets and liabilities.Neuberger Berman Workforce Comparison
Neuberger Berman Emerging is rated number one ETF in number of employees as compared to similar ETFs. The total workforce of Emerging Markets Bond category is currently estimated at about 942. Neuberger Berman maintains roughly 6.0 in number of employees contributing less than 1% to all ETFs under Emerging Markets Bond category.
Neuberger Berman Emerging Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Neuberger Berman Emerging Price Series Summation is a cross summation of Neuberger Berman price series and its benchmark/peer.
About Neuberger Berman Management Performance
The success or failure of an entity such as Neuberger Berman Emerging often depends on how effective the management is. Neuberger Berman management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Neuberger management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Neuberger management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
iNeedMD Holdings, Inc., a medical device development company, researches, develops, markets, and sells medical devices in the United States and internationally. Its product has applications in hospitals, nursing homes and skilled nursing facilities, medical transportation, remote medical assessment, urgent care health clinics, and heart rhythm monitoring. iNeedMD Holdings, Inc. is based in New York, New York. Ineedmd Holdings operates under Medical Appliances Equipment classification in the United States and is traded on OTC Exchange.
The data published in Neuberger Berman's official financial statements typically reflect Neuberger Berman's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Neuberger Berman's quantitative information. For example, before you start analyzing numbers published by Neuberger accountants, it's essential to understand Neuberger Berman's liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Please note, the presentation of Neuberger Berman's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Neuberger Berman's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Neuberger Berman's management manipulating its earnings.
When determining whether Neuberger Berman Emerging is a strong investment it is important to analyze Neuberger Berman's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neuberger Berman's future performance. For an informed investment choice regarding Neuberger Etf, refer to the following important reports: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neuberger Berman Emerging. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
The market value of Neuberger Berman Emerging is measured differently than its book value, which is the value of Neuberger that is recorded on the company's balance sheet. Investors also form their own opinion of Neuberger Berman's value that differs from its market value or its book value, called intrinsic value, which is Neuberger Berman's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuberger Berman's market value can be influenced by many factors that don't directly affect Neuberger Berman's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuberger Berman's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuberger Berman is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuberger Berman's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.